Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Hypertension. 2017 Sep 25;70(5):959–963. doi: 10.1161/HYPERTENSIONAHA.117.09822

Figure 3.

Figure 3

A. Survival data of C57Bl6 mice with ADAM17 antibody treatment. 8 week old C57Bl6 mice infused with AngII (1 µg/kg/min, 4 weeks) and received BAPN (1 mg/mL in drinking water, first 2 weeks) were intraperitoneally injected ADAM17 antibody A9B8 or control human IgG2 (10 mg/kg) at day 1, 7, 14 and 21. B. Telemetry recording of mean arterial blood pressure (MAP) upon 4 week infusion. Control C57Bl6 mice are sham-operated for minipump implantation (n=5).